Skip to main content
. 2020 May 10;92(9):1671–1675. doi: 10.1002/jmv.25932

Table 1.

Performance characteristics (with 95% confidence intervals) of anti‐SARS‐CoV‐2 antibodies IgM and IgG at different cutoff values as determined by CLIA method

Anti‐SARS‐CoV‐2 IgM antibodies
Cutoff value 6.7 AU/mL 7.5 AU/mL 9.4 AU/mL 10.0 AU/mL 11.3 AU/mL 12.2 AU/mL 13.4 AU/mL
Sensitivity 76.7% (59.7‐89.2) 73.3% (56.0‐86.8) 73.3% (56.0‐86.8) 73.3% (56.0‐86.8) 70.0% (52.4 ‐ 84,3) 66.7% (48.9‐81.7) 66.7% (48.9‐81.7)
Specificity 90.6% (81.9‐96.2) 90.6% (81.9‐96.2) 92.2% (84.0‐97.1) 92.2% (84.0‐97.1) 92.2% (84.0 ‐ 97,1) 92.2% (84.0‐97.1) 93.7% (86.1‐98.0)
PPV 79.3% (62.5‐91.2) 78.6% (61.3‐90.9) 81.5% (64.3‐92.9) 81.5% (64.3‐92.9) 80.8% (63.1‐92.6) 80.0% (61.8‐92.3) 83.3% (65.4‐94.5)
NPV 89.2% (80.2‐95.2) 87.9% (78.6‐94.3) 88.1% (78.9‐94.4) 88.1% (78.9‐94.4) 86.8% (77.4‐93.4) 85.5% (76.0‐92.5) 85.7% (76.3‐92.6)
LR+ 8.18 7.82 9.39 9.39 8.96 8.53 10.7
LR− 0.26 0.29 0.29 0.29 0.33 0.36 0.36
OR 31.8 26.6 32.5 32.5 27.5 23.6 30.0
Anti‐SARS‐CoV‐2 IgG antibodies
Cutoff value 5.4 AU/mL 7.1 AU/mL 8.9 AU/mL 10.0 AU/mL 10.7 AU/mL 12.6 AU/mL 15.9 AU/mL
Sensitivity 83.3% (67.5‐93.7) 83.3% (67.5‐93.7) 80.0% (63.6‐91.5) 76.7% (59.7‐89.2) 76.7% (59.7‐89.2) 73.3% (56.0‐86.8) 70.0% (52.4‐84.3)
Specificity 98.45 (93.3‐99.9) 100% (94.3‐100) 100% (94.3‐100) 100% (94.3‐100) 100% (94.3‐100) 100% (94.3‐100) 100% (94.3‐100)
PPV 96.2% (84.1‐99.8)
NPV 92.6% (84.9‐97.3) 92.8% (85.1‐97.3) 91.4% (83.4‐96.5) 90.1% (81.8‐95.6) 90.1% (81.8‐95.6) 88.9% (80.3‐94.8) 87.7% (78.9‐93.9)
LR+ 53.3
LR− 0.17 0.17 0.20 0.23 0.23 0.27 0.30
OR 315

Abbreviations: CLIA, chemiluminescence immunoassay; LR + , positive likelihood ratio; LR−, negative likelihood ratio; NPV, negative predictive value; OR, odds ratio; PPV, positive predictive value.